Soleno Therapeutics Inc header image

Soleno Therapeutics Inc

SLNO

Equity

ISIN null / Valor 121339545

NASDAQ (2026-05-19)

USD 53.01%

Soleno Therapeutics Inc
UMushroom community rating:

4.15 8 votes No rating yet

NegativeNeutralPositive

About company

Soleno Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative treatments for rare diseases. The company's primary focus is on its lead candidate, DCCR (Diazoxide Choline) Extended-Release tablets, which are designed as a once-daily oral treatment for Prader-Willi syndrome (PWS), a complex genetic disorder. Currently, DCCR is undergoing evaluation in a Phase 3 clinical development program. Soleno aims to address unmet medical needs by providing safe and effective therapeutic solutions that enhance the quality of life for patients with life-threatening rare conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-29.9%1Y

995%3Y

250%5Y

Performance

69.9%1Y

127%3Y

116%5Y

Volatility

2763 M

Market cap (USD)

Daily traded volume (Shares)

45.46 / 43.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.15

8 votes

Performance:

4.10

Innovation:

4.15

Society:

3.82

Nature:

3.85

Yiling Guo

United Kingdom, 09 Nov 2025

Good financial performance and under valued

Aditya Jain

United Kingdom, 09 Nov 2025

Good

Meruert Daniyarkyzy

United Kingdom, 09 Nov 2025

Volatile and high risk, but offers notable upside potential if its lead treatment succeeds.

EQUITIES OF THE SAME SECTOR

Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. Valor: 11536062

Annual Return

-50%0%+50%

Risk level

110

1.45%INR 543.55

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

4.17%CHF 324.60

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 20.07

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

1.09%CHF 83.30

Idorsia Ltd

Idorsia Ltd Valor: 36346343

Annual Return

-50%0%+50%

Risk level

110

9.77%CHF 4.45

Alkermes PLC

Alkermes PLC Valor: 13920929

Annual Return

-50%0%+50%

Risk level

110

1.45%USD 43.38

Medacta Group Ltd

Medacta Group Ltd Valor: 46852522

Annual Return

-50%0%+50%

Risk level

110

1.47%CHF 137.80

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

2.44%USD 20.14

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 1.00

Evolva Holding LTD

Evolva Holding LTD Valor: 126205578

Annual Return

-50%0%+50%

Risk level

110

-13.51%CHF 1.60

SIX

FactSet

Clearbit

Logos provided by Clearbit